Concepedia

Periostin promotes the chemotherapy resistance to gemcitabine in pancreatic cancer

Liu Yang, Fan Li, Feng Gao, Lingxi Xing, Peng Qin, Xingxin Liang, Jiajie Zhang, Xiao-Hui Qiao, Lizhou Lin, Qian Zhao,

Tumor Biology · 2016 · 60 citations · 15 references

DOI

Concepts

References

15

Improvements in survival and clinical benefit with gemcitabine as first-line therapy for patients with advanced pancreas cancer: a randomized trial.

Howard A. Burris, Malcolm J. Moore, John Sahl Andersen et al. · Journal of Clinical Oncology · 1997 · 5.9K citations

, , +16

Cancer statistics, 2011

Rebecca L. Siegel, Elizabeth Ward, Otis W. Brawley et al. · CA A Cancer Journal for Clinicians · 2011 · 4.1K citations · Full text

, , +16

Pancreatic Stellate Cells: Partners in Crime with Pancreatic Cancer Cells

Alain Vonlaufen, Swapna Joshi, Changfa Qu et al. · Cancer Research · 2008 · 469 citations

, , +17

<i>STAT3</i> Plays a Critical Role in <i>KRAS</i> -Induced Pancreatic Tumorigenesis

Ryan B. Corcoran, Gianmarco Contino, Vikram Deshpande et al. · Cancer Research · 2011 · 414 citations · Full text

, , +17

Periostin Creates a Tumor-Supportive Microenvironment in the Pancreas by Sustaining Fibrogenic Stellate Cell Activity

Mert Erkan, Jörg Kleeff, Andre Gorbachevski et al. · Gastroenterology · 2007 · 298 citations · Full text

, , +11